---
title: "Tocilizumab Subcutaneous Injection (RoActemra(r))"
ocid: "ocds-r6ebe6-0000638188"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000638188"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000638188.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000638188.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2021-02-03"
---

# Tocilizumab Subcutaneous Injection (RoActemra(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000638188

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000638188)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000638188.json)

## Summary

The procurement process for the supply of Tocilizumab Subcutaneous Injections (RoActemra®) is conducted by The Common Services Agency, commonly known as NHS National Services Scotland (NSS). This procurement falls under the health industry category with key operations located in Edinburgh, UK. The process is currently at the Award stage, having been completed on 10 December 2020. The contract is valued at approximately £25,050,684 and was initiated under a limited procurement method without prior publication, following the expiration of the patent for this medication.

This tender presents significant opportunities for businesses, particularly those in the pharmaceuticals and healthcare sectors, to engage with NHS Scotland. Companies that specialise in supply chain management, pharmaceutical distribution, or those with capabilities in manufacturing health-related products would be well-suited to compete. Given the absence of anticipated competition in the UK market for Tocilizumab, businesses that can demonstrate reliability and compliance with public health standards may find themselves well-positioned to benefit from future contracts in similar domains.

## Notice

The supply of Tocilizumab Subcutaneous Injections (RoActemra(r)) to NHS Scotland which used to treat licensed indications. This medicine is not being procured to treat Covid-19.

### Lot Information

Lot 1

Supply of Tocilizumab Subcutaneous Injections (RoActemra(r)) to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line.

### Procurement Information

The patent for Tocilizumab (RoActemra(r)) has expired December 2020, there is no known competition that has entered the UK market place and there is none anticipated for the initial duration of the framework agreement.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB405683 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Feb 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 10 Dec 2020 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £25,050,684 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 3 Feb 2021 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB405683
- 10 Dec 2020 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC402035

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=DEC402035
  Tocilizumab Subcutaneous Injection (RoActemra(r)) - The supply of Tocilizumab Subcutaneous Injections (RoActemra(r)) to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB405683
  Tocilizumab Subcutaneous Injection (RoActemra(r)) - The supply of Tocilizumab Subcutaneous Injections (RoActemra(r)) to NHS Scotland which used to treat licensed indications. This medicine is not being procured to treat Covid-19.

## Notice URLs

- http://
- http://www.nhsscotlandprocurement.scot.nhs.uk/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000638188

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000638188. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000638188.json.